| Theravance Earns $20 Million Milestone Under Telavancin Collaboration Agreement - dBusinessNews San Francisco (press release) |
|
|
dBusinessNews San Francisco (press release)New onset or worsening renal impairment occurred in patients who received VIBATIV. Renal adverse events were more likely to occur in patients with baseline ... read more |